active
ACTIVE SINCE: 2011-2022

GSK – The University of Dundee collaborations on Neglected Tropical Diseases (NTDs) treatments

Accelerate research into discovering and developing effective Neglected Tropical Diseases (NTD) treatments.
SGDS CONTRIBUTING TO:
SHOW SUB-TARGETS + HIDE SUB-TARGETS -
MEMBER COMPANIES:
Private Foundation or Development Organization 1
Academia or research institute 1
Objectives
  • Accelerate research into discovering and developing effective Neglected Tropical Diseases (NTD) treatments.

GSK and the Drug Discovery Unit (DDU) at the University of Dundee have a long-standing partnership to research Neglected Tropical Diseases (NTDs). In April 2017, the Wellcome Trust awarded the University of Dundee £7.9m for a joint five-project with GSK to boost efforts to find new drugs to treat some of the world’s most devastating parasitic diseases – visceral and cutaneous leishmaniasis, and Chagas’ disease.

Quote
"The collaboration with the University of Dundee and this funding from Wellcome are vital boosts towards the achievement of GSK’s goal of producing new preclinical candidates for leishmaniasis and/or Chagas’ disease."
 Dr Jose Fiandor
Director of GSK’s Kinetoplastids Discovery Performance Unit
Geographic Reach
  • Global Commitment
Disease Area
Target Population
  • Marginalized/indigenous people
  • People with low incomes
Partner organizations
Private Foundation or Development Organization

Wellcome Trust

Academia or research institute

University of Dundee